Dear colleagues
,
through this questionnaire we like to get a better sight about the preparation situation in Europe.
As we have so much different national conditions for serving cancer patients with cytotoxic drugs we like to get an update about the present service.
Please feel free to answer as soon as possible .
We like to provide you with the result in 2 month.
Many thanks in advance for your support.
1. Do you have the possibility to prepare chemotherapy in your pharmacy under safe conditions?
Yes
No
If NO, with whom do you work with?
Other pharmacies
Compounders
Chemotherapy is prepared on the ward
2. How many chemotherapies do you prepare per year?
Up to 2000
2001-5000
5001-10000
More than 10000
3. What is the percentage of discarded preparations per year, caused by delay of therapy or patients that do not show up
%
4. Do you prepare chemotherapy in advance?
Yes If YES, how long in advance?:
Days
No
By way of exception
5. What is the accepted tolerance limit between the calculated dose according to body surface area and the actual dose prepared?
0%, not accepted at all
Up to 3%
3-5% Up to
%
6. On what basis has the decision on the chosen tolerance limit been made?
Internal coordination (Pharmacists and Oncologists)
According to Pharm.Eur
Others - please specify
7. What country are you from?
Afghanistan
Albania
Algeria
Angola
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Belgium
Bhutan
Bolivia
Bosnia and Herzegovina
Brazil
Bulgaria
Canada
Chile
China
Christmas Island
Colombia
Congo
Congo, Democratic Republic
Costa Rica
Croatia (Hrvatska)
Cuba
Cyprus
Czech Republic
Denmark
Dominican Republic
Ecuador
Egypt
El Salvador
Estonia
Ethiopia
Fiji
Finland
France
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guatemala
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kazakhstan
Korea (south)
Kuwait
Kyrgyzstan
Latvia
Lebanon
Liechtenstein
Lithuania
Luxembourg
Macedonia, Former Yugoslav Republic Of
Mali
Malta
Mexico
Moldova
Montenegro
Morocco
Namibia
Netherlands
Netherlands Antilles
New Zealand
Nicaragua
Norway
Pakistan
Palestinian Territories
Philippines
Poland
Portugal
Romania
Russian Federation
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
Somalia
South Africa
Spain
Sweden
Switzerland
Syria
Taiwan
Thailand
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States of America
Venezuela
Vietnam